603229 奧翔藥業
按盤價 
10.250 +0.420 (+4.273%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.170 | 5.750 | 9.371 | 14.095 | 17.333 |
| 總資產報酬率 ROA (%) | 3.097 | 4.304 | 6.970 | 9.641 | 11.330 |
| 投入資產回報率 ROIC (%) | 3.351 | 4.748 | 7.874 | 11.433 | 13.573 | 邊際利潤分析 |
| 銷售毛利率 (%) | 62.389 | 53.509 | 54.233 | 55.048 | 51.501 |
| 營業利潤率 (%) | 34.783 | 17.666 | 30.322 | 35.607 | 33.708 |
| 息稅前利潤/營業總收入 (%) | 41.512 | 18.040 | 27.238 | 31.479 | 27.939 |
| 淨利潤/營業總收入 (%) | 31.315 | 16.470 | 26.002 | 31.086 | 30.786 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 106.905 | 88.638 | 91.510 | 96.382 | 98.049 |
| 價值變動淨收益/利潤總額(%) | 0.797 | 15.802 | 11.809 | 0.241 | 2.473 |
| 營業外收支淨額/利潤總額(%) | -0.033 | -1.553 | -0.393 | -0.021 | -0.725 | 償債能力分析 |
| 流動比率 (X) | 2.642 | 2.466 | 2.534 | 2.172 | 1.525 |
| 速動比率 (X) | 2.125 | 1.925 | 1.939 | 1.699 | 1.095 |
| 資產負債率 (%) | 25.014 | 26.445 | 23.823 | 27.443 | 36.893 |
| 帶息債務/全部投入資本 (%) | 18.826 | 18.006 | 14.167 | 14.951 | 20.263 |
| 股東權益/帶息債務 (%) | 424.963 | 448.320 | 596.424 | 558.661 | 384.038 |
| 股東權益/負債合計 (%) | 299.776 | 278.144 | 319.760 | 264.394 | 171.056 |
| 利息保障倍數 (X) | 6.159 | 28.001 | -9.187 | -7.639 | -5.056 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 66.883 | 75.893 | 73.551 | 58.966 | 47.334 |
| 存貨周轉天數 (天) | 296.963 | 390.341 | 378.875 | 336.194 | 273.793 |
| 備註： | 即時報價更新時間為 06/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
